| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| QNCX | Quince Therapeutics, Inc. | Lamond David | Director | Dec 12, 2023 | Buy | $1.02 | 22,327 | 22,774 | 2,302,291 | Dec 14, 2023, 06:21 PM | |
| QNCX | Quince Therapeutics, Inc. | Lamond David | Director | Dec 12, 2023 | Buy | $1.00 | 300 | 300 | 2,279,964 | Dec 14, 2023, 06:21 PM | |
| QNCX | Quince Therapeutics, Inc. | Lamond David | Director | Dec 13, 2023 | Buy | $1.00 | 22,627 | 22,627 | 2,324,918 | Dec 14, 2023, 06:21 PM | |
| QNCX | Quince Therapeutics, Inc. | Lamond David | Director | Dec 14, 2023 | Buy | $1.04 | 22,627 | 23,532 | 2,347,545 | Dec 14, 2023, 06:21 PM | |
| QNCX | Quince Therapeutics, Inc. | Lamond David | Director | Dec 07, 2023 | Buy | $1.01 | 19,123 | 19,314 | 2,279,664 | Dec 07, 2023, 06:30 PM | |
| QNCX | Quince Therapeutics, Inc. | Lamond David | Director | Dec 05, 2023 | Buy | $1.01 | 19,123 | 19,314 | 2,241,418 | Dec 07, 2023, 06:30 PM | |
| QNCX | Quince Therapeutics, Inc. | Lamond David | Director | Dec 06, 2023 | Buy | $1.02 | 19,123 | 19,505 | 2,260,541 | Dec 07, 2023, 06:30 PM | |
| QNCX | Quince Therapeutics, Inc. | Lamond David | Director | Nov 29, 2023 | Buy | $0.98 | 14,378 | 14,090 | 2,193,539 | Dec 01, 2023, 01:38 PM | |
| QNCX | Quince Therapeutics, Inc. | Lamond David | Director | Nov 30, 2023 | Buy | $0.90 | 14,378 | 12,940 | 2,207,917 | Dec 01, 2023, 01:38 PM | |
| QNCX | Quince Therapeutics, Inc. | Lamond David | Director | Dec 01, 2023 | Buy | $0.94 | 14,378 | 13,515 | 2,222,295 | Dec 01, 2023, 01:38 PM | |
| QNCX | Quince Therapeutics, Inc. | Lamond David | Director | Aug 31, 2023 | Buy | $1.32 | 41,026 | 54,154 | 2,179,161 | Aug 31, 2023, 06:42 PM | |
| QNCX | Quince Therapeutics, Inc. | Lamond David | Director | Aug 30, 2023 | Buy | $1.31 | 41,026 | 53,744 | 2,138,135 | Aug 31, 2023, 06:42 PM | |
| QNCX | Quince Therapeutics, Inc. | Lamond David | Director | Aug 15, 2023 | Buy | $1.32 | 107,886 | 142,410 | 1,954,995 | Aug 17, 2023, 06:08 PM | |
| QNCX | Quince Therapeutics, Inc. | Lamond David | Director | Aug 16, 2023 | Buy | $1.29 | 117,348 | 151,379 | 2,072,343 | Aug 17, 2023, 06:08 PM | |
| QNCX | Quince Therapeutics, Inc. | Lamond David | Director | Aug 17, 2023 | Buy | $1.29 | 24,766 | 31,948 | 2,097,109 | Aug 17, 2023, 06:08 PM | |
| AMTI | Applied Molecular Transport Inc. | Lamond David | Director | May 23, 2022 | Buy | $3.26 | 33,500 | 109,210 | 1,077,519 | May 23, 2022, 06:18 PM | |
| AMTI | Applied Molecular Transport Inc. | Lamond David | Director | May 20, 2022 | Buy | $3.08 | 33,000 | 101,640 | 1,044,019 | May 23, 2022, 06:18 PM | |
| CRTX | Cortexyme, Inc. | Lamond David | Director | Mar 24, 2021 | Buy | $33.77 | 50,000 | 1,688,500 | 1,847,109 | Mar 24, 2021, 09:06 PM | |
| CRTX | Cortexyme, Inc. | Lamond David | Director | Mar 04, 2021 | Buy | $35.34 | 50,000 | 1,767,057 | 1,797,109 | Mar 05, 2021, 05:54 PM | |
| AMTI | Applied Molecular Transport Inc. | Lamond David | Director | Jun 09, 2020 | Option Exercise | $14.00 | 71,430 | 1,000,020 | 986,019 | Jun 11, 2020, 06:38 PM | |
| CRTX | Cortexyme, Inc. | Lamond David | Director | Jun 04, 2020 | Buy | $43.27 | 49,125 | 2,125,795 | 1,747,109 | Jun 08, 2020, 06:47 PM | |
| CRTX | Cortexyme, Inc. | Lamond David | Director | May 15, 2020 | Buy | $48.93 | 5,448 | 266,569 | 1,658,784 | May 19, 2020, 06:41 PM | |
| CRTX | Cortexyme, Inc. | Lamond David | Director | May 19, 2020 | Buy | $56.24 | 39,200 | 2,204,683 | 1,697,984 | May 19, 2020, 06:41 PM | |
| CRTX | Cortexyme, Inc. | Lamond David | Director | Feb 10, 2020 | Option Exercise | $50.00 | 30,000 | 1,500,000 | 1,653,336 | Feb 10, 2020, 06:18 PM |
Menu